Remotely adjustable gastric banding system

Information

  • Patent Grant
  • 8517915
  • Patent Number
    8,517,915
  • Date Filed
    Thursday, June 10, 2010
    14 years ago
  • Date Issued
    Tuesday, August 27, 2013
    11 years ago
Abstract
An implantable system comprises a housing that includes a flexible reservoir. The flexible reservoir is coupled to an inflatable portion of a gastric band via a fluid inlet/outlet. The flexible reservoir contains a fluid and has an expanded configuration and a contracted configuration. An access port may be coupled to the flexible reservoir and/or the gastric band to facilitate filling and draining the reservoir and/or the gastric band. A movable wall is slidably positioned around the flexible reservoir to move the flexible reservoir between the expanded configuration and the contracted configuration to move the fluid into and out of the inflatable portion of the gastric band. A driving mechanism is positioned around the movable wall and is capable of changing the size of the movable wall to compress or expand the flexible reservoir. A motor, coupled to the driving mechanism, may actuate the driving mechanism.
Description
FIELD

The present invention generally relates to medical systems and apparatus and uses thereof for treating obesity and/or obesity-related diseases, and more specifically, relates to gastric banding systems that are remotely adjustable.


BACKGROUND

Adjustable gastric banding apparatus have provided an effective and substantially less invasive alternative to gastric bypass surgery and other conventional surgical weight loss procedures. Despite the positive outcomes of invasive weight loss procedures, such as gastric bypass surgery, it has been recognized that sustained weight loss can be achieved through a laparoscopically-placed gastric band, for example, the LAP-BAND® (Allergan, Inc., Irvine, Calif.) gastric band or the LAP-BAND AP® (Allergan, Inc., Irvine, Calif.) gastric band. Generally, gastric bands are placed about the cardia, or upper portion, of a patient's stomach forming a stoma that restricts the food's passage into a lower portion of the stomach. When the stoma is of an appropriate size that is restricted by a gastric band, the food is held in the upper portion of the stomach provides a feeling of satiety or fullness that discourages overeating. Unlike gastric bypass procedures, gastric band apparatus are reversible and require no permanent modification to the gastrointestinal tract.


Over time, a stoma created by a gastric band may need adjustment in order to maintain an appropriate size, which is neither too restrictive nor too passive. Accordingly, prior art gastric band systems provide a subcutaneous fluid access port connected to an expandable or inflatable portion of the gastric band. By adding fluid to or removing fluid from the inflatable portion by means of a hypodermic needle inserted into the access port, the effective size of the gastric band can be adjusted to provide a tighter or looser constriction. Naturally, it would be desirable to allow for non-invasive adjustment of gastric band constriction, for example, without the use of a hypodermic needle.


Birk, et al., U.S. Patent Pub. No. 2010-0010291, and Birk, et al., U.S. Ser. No. 12/705,245, which are commonly-assigned and co-pending with the present application, are incorporated herein in their entirety by this specific reference. Both of these applications disclose certain approaches to implantable pumping systems that may be relevant.


Jordan, et al., U.S. Patent Application Pub. Nos. 2008/0108862 and 2005/0104457, and Jordan, et al., U.S. Pat. No. 7,314,443 generally disclose an implantable device that utilizes a stepper motor to move a fluid utilized by the implantable device. However, these documents do not disclose a system for changing a diameter of a reservoir to inflate an inflatable portion of a gastric band.


Bachmann, U.S. Patent Application Pub. Nos. 2008/0002746 and 2005/0251182, Bachmann, et al., U.S. Patent Application Pub. Nos. 2005/0143766 and 2005/0143765, and Bachmann, U.S. Pat. No. 7,238,191 generally disclose a surgical ring that has an adjustable diameter. The diameter is adjusted using a screw thread that lengthens and shortens using a motor. However, these documents do not disclose a system for moving fluid from a reservoir to an inflatable portion of a gastric band.


Forsell, U.S. Patent Application Pub. No. 2001/0011543 and Forsell, U.S. Pat. No. 6,210,347, generally disclose an adjustable implantable device for restricting an opening in the body that food passes through. The implantable device is mechanically adjustable, but these documents do not disclose a system for adjusting the implantable device using fluid from a flexible reservoir.


Some mechanically adjustable implantable devices have a disadvantage of becoming inoperable if the adjustment mechanism fails. Furthermore, because the motor and the driving mechanisms are located near the restricting band itself, they are more subject to strain and damage from the implantation process. Therefore, it is desirable to develop a remotely adjustable gastric band where the motor is separated from the restricting band to reduce the strain from the implantation process such that the risk of damage during implantation is decreased.


Some attempts have been made to use piezoelectric pumps to drive fluid into an inflatable portion of a gastric band, but these pumps may not provide sufficient pumping power and/or may not satisfy other design specifications. Thus, it is desirable to develop a more efficient pumping mechanism.


Additionally, some attempts have been made to utilize a piezoelectrically driven bellows infuser to inflate an inflatable portion of a gastric band. However, these bellows infusers do not offer a reduced area against which pressure is applied after an amount of fluid has been pumped into the gastric band, which may result in higher power requirements and more energy dissipation. Therefore, it is desirable to develop a pumping mechanism that offers efficiencies as fluid is moved from a reservoir to a gastric band.


Further, some attempts have been made to measure pressure in various components of implantable systems. But these pressure measurements have generally been limited to measuring pressure in an injection port or in an organ such as the stomach. Therefore, it is desirable to develop a flexible reservoir with a means for measuring the pressure in the reservoir itself.


Thus, there continues to remain a need for more effective implantable pump systems for use with adjustable gastric bands, particularly such implantable pump systems with increased and more efficient pumping capability.


SUMMARY

Generally described herein are remotely adjustable and powered gastric banding systems. The apparatus and systems described herein aid in facilitating obesity control and/or treating obesity-related diseases while being non-invasive once implanted.


In one embodiment, an implantable system comprises a housing that has a fluid inlet/outlet and a flexible reservoir positioned within the housing. The flexible reservoir is coupled to an inflatable portion of a gastric band via the fluid inlet/outlet. The flexible reservoir contains a fluid and has an expanded configuration and a contracted configuration.


A movable wall is slidably positioned around the flexible reservoir and forms a cylinder around the flexible reservoir. The movable wall has a diameter that may be changed by moving the ends of the movable wall. A driving mechanism, such as a flexible screw, is positioned around the movable wall, and is capable of changing the diameter of the movable wall to compress the flexible reservoir from the expanded configuration to the contracted configuration. When the flexible reservoir is compressed, a portion of the fluid in the flexible reservoir moves into the inflatable portion of the gastric band. The implantable system may also move the fluid out of the inflatable portion of the gastric band. A motor, coupled to the driving mechanism, may actuate the driving mechanism.


In an embodiment, the movable wall has a first end and a second end. The first end of the movable wall and the second end of the movable wall may be freely movable within the housing, or one of the two ends may be fixed to the housing. Furthermore, one end of the flexible screw may be attached to the housing.


Additionally, in an embodiment, the implantable system comprises a compressible structure positioned within the flexible reservoir. The compressible structure facilitates stabilizing boundaries of the flexible reservoir. The compressible structure may be selected from a group consisting of a tube, a sponge material, a synthetic material, a flexible material, and combinations thereof.


A sensing coil unit may be located near the sternum of a patient and may communicate with an external controller via radio frequency signals. The sensing coil unit may provide power and communications to the motor.


In various embodiments, a spring may be positioned around the movable wall to facilitate moving the movable wall. For example, the spring may be an elastic spring, a polymer spring, a stretchable spring, a coplanar spring, a sheath spring, an enclosing spring and/or combinations thereof. The spring may resist or assist the motor in expanding or contracting the movable wall.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates a gastric banding system according to an embodiment of the present invention.



FIGS. 2A and 2B illustrate a location of a gastric banding system within a patient's body according to an embodiment of the present invention.



FIG. 3A illustrates a top, cross-sectional view of a reservoir unit according to an embodiment of the present invention.



FIG. 3B illustrates a side, cross-sectional view of the reservoir unit of FIG. 3A according to an embodiment of the present invention.



FIG. 4A illustrates a top, cross-sectional view of a reservoir unit with a compressible structure according to an embodiment of the present invention.



FIG. 4B illustrates a side, cross-sectional view of the reservoir unit of FIG. 4A according to an embodiment of the present invention.



FIG. 4C illustrates a perspective, cut-away view of a reservoir unit having a movable wall according to an embodiment of the present invention.



FIG. 4D illustrates a perspective, cut-away view of a reservoir unit having posts to guide a movable wall according to an embodiment of the present invention.



FIG. 4E illustrates a perspective view of a reservoir unit with an access port according to an embodiment of the present invention.



FIG. 4F illustrates a perspective, cut-away view of the reservoir unit with an access port according to FIG. 4E.



FIG. 4G illustrates another perspective, cut-away view of the reservoir unit with an access port according to FIG. 4E.



FIG. 5 illustrates a perspective view of a movable wall, a spring, and a driving mechanism according to an embodiment of the present invention.



FIGS. 6A-6C illustrate perspective views of a sheath, a driving mechanism, and a motor according to various embodiments of the present invention.



FIG. 6D illustrates a perspective, cut-away view of a reservoir unit having a sheath according to an embodiment of the present invention.



FIG. 7 illustrates a perspective view of a reservoir unit with an access port and/or other components according to an embodiment of the present invention.



FIG. 8 illustrates a force and pressure diagram of a reservoir unit according to an embodiment of the present invention.





DETAILED DESCRIPTION

The present invention generally provides remotely adjustable gastric banding systems, for example, for treatment of obesity and obesity related conditions, as well as systems for controlling inflation of gastric banding systems.


A remotely adjustable gastric band is a medical device which allows a healthcare worker to adjust a gastric band without utilizing hypodermic needles to connect to an implanted access port. An external, handheld controller can be used to send radio frequency signals for powering and communicating with the implanted device. The implanted device can fill or drain the gastric band as requested by the healthcare worker via the handheld controller. The handheld controller may be a remote device configured to produce a telemetric signal that controls the various components of the gastric banding system.


The filling and draining of the band is accomplished by a set of fluidic elements including pumps, valves, and sensors which monitor and/or move fluid between the gastric band and a reservoir. In accordance with various embodiments, different numbers, types, and orientations of the fluidic elements may be utilized to obtain the desired results. Any and/or all of these various components may be configured to be controlled by a remote transmitter, such as a handheld controller.


Turning now to FIG. 1, a gastric banding system 100 includes a gastric band 105, a reservoir unit 108, a motor housing 112, an access port 114, and a receiving coil unit 116. The flexible tubing 106 connects the gastric band 105 and the access port 114 to the reservoir unit 108. Each of the components of the system 100 is implantable in a patient using conventional surgical techniques. The reservoir unit 108 and the coil unit 116 may be used instead of or in addition to the conventional access port 114.


The reservoir unit 108 may move precisely metered volumes of fluid (e.g., saline, a drug, and/or combinations thereof) from the reservoir unit 108 through the flexible tubing 106 into the gastric band 105. The reservoir unit 108 may comprise a compressible reservoir, such as an elastic polymer, a balloon, a rubber container, a silicone container, a collapsible container, a non-elastomeric container, a bellows, and combinations thereof that are configured to contain the fluid. The motor housing 112 includes a motor configured to compress the compressible reservoir in order to fill or drain the gastric band 105.


Moving the fluid into the gastric band 105 causes inflation of at least one bladder, or inflatable member of the gastric band 105 and constricts around the cardia, or upper portion of the stomach, forming a stoma that restricts the passage of food into a lower portion of the stomach. This stoma can provide a patient with a sensation of satiety or fullness that discourages overeating. In contrast, moving the fluid out of at least one inflatable member of the gastric band 105 contracts the pressure around the cardia and allows a stoma to be at least partially released and regains the patient's hunger sensation.


The receiving coil 116 receives radio frequency signals from an external/remote handheld controller or transmitter to control operation of the system 100. Although “transmitter” may be used herein, it should be understood that the remote transmitter may also be a wireless receiver and/or transceiver operable to take readings from the system 100 to determine the amount of fluid entering and/or exiting the gastric band 105, and/or to send or receive other types of information associated with the gastric banding system 100.


In various embodiments, the remote transmitter provides access to system data and functions and is an external, handheld, reusable battery-powered device. The remote transmitter can be made of any rugged plastic material including, polypropylene, cyclicolephin co-polymer, nylon, and other compatible polymers and the like. Further, the remote transmitter has a user interface including at least one display and at least one user input. The remote transmitter permits a clinician or a patient to navigate through menu driven screens used for data entry, data collection, and control of the gastric banding system 100.


The remote transmitter is capable of communicating with the gastric banding system 100. “Capable of communicating” as used herein refers to the remote transmitter's ability to establish communications with the gastric banding system 100, yet still have the ability to break communication and the systems described herein still function. To establish communication, in one example embodiment, once the remote transmitter is initialized, a display shows a searching query for a nearby gastric banding system 100. As the remote transmitter is brought into range of the gastric banding system 100, the display shows the strength of the communication link. Once stable communications have been acquired, the display shows the serial number (or other unique patient data) of the system so a clinician can verify they have the appropriate patient records in hand. If the patient requires a tightening of the gastric band 105, the clinician can enter the amount of the desired volume increase. The remote transmitter can also display the current volume within the gastric band 105 and indicate the new volume as the gastric band 105 fills. The remote transmitter can also indicate desired and actual volumes during the gastric band 105 draining.


In accordance with various embodiments, the gastric banding system 100 allows for a remotely controlled adjustment without needles, non-invasively, by using the remote transmitter. A conventional access port 114 may be included as part of system 100 in order to provide alternate filling and draining capabilities, for example, to provide a fail-safe alternative in case the non-invasive functionality (e.g., motor, electronics, driving mechanism) becomes inoperative and/or ineffective. The access port 114 may be used to extract fluid from the system in case of an emergency or as a safety measure. However, non-invasively filling and draining the gastric band 105 using the reservoir unit 108 represents advantages over gastric banding systems that only use standard access ports. The access port 114 may further be used to prime the system with a desired amount of fluid upon implantation.


When compared to conventional gastric banding systems having standard access ports which exclusively require syringe access, the presently described systems and apparatus offer several benefits. First, for conventional access ports located under a thick layer of fatty tissue, which is generally the case as the devices are typically used to treat obesity, the access port can be difficult to locate. The present systems reduce or eliminate the need for port location as the use of the remote transmitter removes the necessity of adjustment using a syringe.


Secondly, accessing the access port in conventional systems, when there is ambiguity on its location, can cause damage by accidentally puncturing the tubing which connects the access port to the gastric band. This damage can require another surgery in order to repair the punctured tubing. Further, when a conventional access port cannot be located by palpation, x-ray imaging may be required to guide a needle into the access port. Such imaging practices put a patient at risk for x-ray radiation exposure. The present systems and apparatus remove the need for these unnecessary procedures and save the patient from x-ray radiation exposure. As described herein, the present systems and apparatus may be compatible with magnetic resonance imaging (MRI), which is much safer for a patient.


The fluids used within the systems include any fluid that is biocompatible and incompressible. The fluid has no adverse effect on the patient in the unlikely event that a leak emanates from the system. The fluid can simply be water or any biocompatible polymer oil such as castor oil. In an example embodiment, the fluid is saline, a drug, and/or combinations thereof. The tubing 106 connects certain components of the system 100 and comprises any biocompatible flexible tubing that does not degrade in vivo. The tubing 106 is configured to withstand hydraulic forces up to hundreds of psi without leakage.


According to various embodiments, and with reference to FIGS. 2A-2B, components of the gastric banding system 200 may be placed in their respective positions within a patient 201 using common surgical techniques. The surgical techniques may be similar to those used in the placement of conventional gastric banding systems. For example, the gastric band 205 may be placed around the stomach using laparoscopic techniques, as known to those of skill in the art.


Like a conventional access port, various components of the gastric banding system 200 may be sutured onto the rectus muscle sheath 202 or any other conveniently accessible muscle. For example, the access port 214 and/or the reservoir unit 208 may be sutured to the rectus muscle sheath 202. The rectus muscle sheath 202 provides a secure surface on which to attach the access port 214 under a layer of fat 203 that separates the patient's skin 204 from the muscle 202.


The receiving coil unit 216 may be located near the sternum of the patient 201, and a wire 217 may electronically couple the receiving coil unit 216 to the reservoir unit 208. In an embodiment as illustrated in FIGS. 2A-2B, the reservoir unit 208 is located in the peritoneal cavity of the patient 201. In other embodiments, the components of system 200 may be positioned in other locations in the patient 201 to facilitate filling or draining of the gastric band 205. For example, in an embodiment, the access port 214 may be incorporated into the housing 208, such that the housing 208 may be implanted on the rectus muscle sheath.


Turning to FIGS. 3A-3B, in an embodiment, the reservoir unit 308 comprises a housing 309 that is rigid and generally cylindrical in shape. A flexible pouch or reservoir 310 is disposed in the housing 309. The flexible pouch 310 may be a compressible pouch, an elastic polymer, a balloon, a rubber container, a silicon container, and/or combinations thereof. Further, the flexible pouch 310 may be formed in the shape of a donut, a circle, an ellipse, a rectangle, and combinations thereof.


A movable wall 320 wraps around the flexible pouch 310, with one end of the movable wall 320 overlapping the other end of the movable wall 320 such that the movable wall 320 forms a cylinder within which the flexible pouch 310 is located. Although “cylinder” is used to describe the shape of the movable wall 320 in the reservoir unit 308, it should be understood that the movable wall 320 may form any shape that is capable of compressing or expanding the flexible pouch 310. For example, the movable wall 320 may form an extended ellipse, oval, rectangle or other shape.


The movable wall 320 may have a constant height and/or thickness, or it may have a variable height and/or thickness. In an embodiment, the movable wall 320 may be disposed and/or covered in a material that reduces friction between the overlapping ends of the movable wall 320. For example, the movable wall 320 may be wrapped in a shrinkable Teflon (PTFE) tube.


As the ends of the movable wall 320 overlap to a greater extent, the diameter of the cylinder formed by the movable wall 320 decreases. Although “diameter” is used to describe a dimension of a cylinder, it should be understood that other geometric shapes of the movable wall 320 have other characteristic dimensions, and these dimensions may change as the movable wall 320 compresses or expands the flexible pouch 310.


The size and/or volume of the flexible pouch 310 decreases as the ends of the moveable wall 320 overlap to a greater degree. As the size of the flexible pouch 310 decreases, fluid is expelled from the flexible pouch 310 and is moved into the gastric band. On the other hand, as the diameter of the cylinder created by the movable wall 320 increases (i.e., the ends of the movable wall 320 overlap less), the size and/or volume of the flexible pouch 310 increases and fluid is drawn out of the gastric band into the flexible pouch 310.


The reservoir unit 308 comprises an inlet/outlet port 340 for allowing fluid to pass bidirectionally between the flexible pouch 310 and the access port. The reservoir unit further comprises an inlet/outlet port 342 for allowing fluid to pass bidirectionally between the flexible pouch 310 and the gastric band. The ports 340 and 342 are barbed to facilitate attachment to the flexible tubing and to allow bidirectional flow of the fluid into and out of the flexible pouch 310. The ports 340 and 342 may comprise one or more flow control devices for controlling movement of the fluid into or out of the flexible pouch 310. The flow control devices may be a valve, a tube, a regulator, and/or combinations thereof. Other embodiments may not include a flow control device.


In an embodiment, a motor 335 is disposed within the motor housing 312, and the motor 335 drives a driving mechanism 330, such as a rod, a string, a screw, or combinations thereof. In an embodiment, the driving mechanism 330 comprises a flexible screw, and in other embodiments, the driving mechanism 330 is partially a flexible screw and partially a string, a cord, a rod, a cable, or other flexible member. The motor 335 is coupled to the receiving coil unit via a wire 317. The motor 335 may be a piezoelectric motor, an electromagnetic motor, an AC motor, a DC motor, a stepper motor, and/or combinations thereof. Furthermore, the motor 335 may move the driving mechanism 330 by rotational and/or translational movement.


The driving mechanism 330 wraps around the movable wall 320 to facilitate increasing or decreasing the diameter of the cylinder formed by the movable wall 320. For example, as the driving mechanism 330 exits the housing 309 of the reservoir unit 308 through the motor 335 and into the motor housing 312, the diameter of the cylinder formed by the movable wall 320 decreases. Similarly, as the driving mechanism 330 enters the housing 309 of the reservoir unit 308, the diameter of the cylinder formed by the movable wall 320 increases.


The driving mechanism 330 may enter the housing 309 through the motor 335, and the motor may extend and withdraw the driving mechanism 330 into and out of the housing 309. The driving mechanism 330 wraps around the movable wall 320 to facilitate changing the diameter of the cylinder formed by the movable wall.


In one embodiment, as illustrated in FIG. 3A, one end of the driving mechanism 330 attaches to the housing 309 near the point where the mechanism 330 enters the housing 309, or near the motor 335. The mechanism 330 may pass through a loop or other guiding structure on the movable wall 320 to facilitate expanding and contracting of the diameter of the movable wall 320. In other embodiments, the driving mechanism 330 may not be attached or connected to the movable wall 320.


With one end of the driving mechanism 330 fixed to the housing 309, as the motor 335 draws the driving mechanism 330 out of the housing 309 and into the motor housing 312, the total length of the driving mechanism 330 in the housing 309 decreases, which causes the ends of the movable wall 320 to overlap to a greater degree. This greater overlap causes the size and/or volume of the flexible pouch 310 to decrease. In this configuration, where one end of the driving mechanism 330 is fixed to the housing 309, the motor 335 may be capable of exerting a greater force on the driving mechanism 330 than in the configuration where the driving mechanism 330 is attached directly to the movable wall 320. Thus, more friction between the overlapping ends of the movable wall 320 may be overcome where the driving mechanism 330 is fixed to the housing 309.


The movable wall 320 may move freely within the housing 309. In an embodiment, the movable wall 320 may move within tracks, guides, and/or paths in the housing 309. In another embodiment, guide posts or bearings may be utilized to guide the motion of the movable wall 320 within the housing 309.


As noted above, the size of the flexible pouch 310 changes as the diameter of the cylinder formed by the movable wall 320 changes. This change in diameter is accomplished by changing the length of the driving mechanism 330 within the housing 309. Thus, by knowing the length of the driving mechanism 330, either inside or outside the housing 309, the size and/or volume of the flexible pouch 310 may be determined, and accordingly, the amount of fluid within the gastric band may be determined.


In an embodiment, the external controller may display an estimated volume of fluid within the gastric band based on a distance traveled by the driving mechanism 330. The length of the driving mechanism 330 may be advantageously determined to provide a desired range of volumes within the gastric band and/or the flexible pouch 310. Furthermore, a sufficient amount of space within the motor housing 312 and the housing 309 of the reservoir unit 308 is designed to allow the driving mechanism 330 to have the desired range of motion.


In another embodiment, and with reference to FIGS. 4A-4D, the movable wall 420 has a first end 422 that is attached to the housing 409 of the reservoir unit 408. The first end 422 remains stationary with respect to the housing 409 as the driving mechanism 430 is moved into and out of the housing 409. A tab 427 may be utilized to maintain a portion of the movable wall 420 in a fixed position with respect to the housing 409.


A second end 423 of the movable wall 420 is attached to the driving mechanism 430. As the driving mechanism 430 moves into and out of the housing 409, the second end 423 of the movable wall 420 moves with the driving mechanism 430 to cause the first end 422 to overlap to a greater or lesser degree with the second end 423. As the degree of overlap of the first and second ends 422 and 423 increases or decreases, the diameter of the cylinder formed by the movable wall 420 correspondingly decreases and increases, as discussed above.


Although the movable wall 420 may move freely within the housing 409, guides, rods, bearings, and combinations thereof may be utilized to guide the movement of the movable wall 420. For example, with reference to FIG. 4D, in one embodiment, posts 425 are utilized to guide the movable wall 420. The first end 422 of the movable wall 420 may attach to one of the posts 425 (e.g., the second post from the first end 422 of the movable wall 420), and the second end 423 may attach to the driving mechanism 430.


In various embodiments as illustrated in FIGS. 4A-4D, variations of the location of the driving mechanism 430 on the movable wall 420 may be permissible. Because the driving mechanism 430 is attached to the second end 423 of the movable wall, the driving mechanism 430 may still facilitate appropriate movement of the movable wall 420 even if the driving mechanism 430 is not vertically in the center of the movable wall 420.


With reference to FIG. 4B, the access port inlet/outlet 440 of the reservoir unit 408 is located on the same side of the reservoir unit 408 as the gastric band inlet/outlet 442. In such a configuration, if the motor 435 and/or the reservoir unit 408 were to fail, the access port can still be used to fill and drain the gastric band. Furthermore, locating the inlets/outlets 440, 442 on the same side of the reservoir unit 408 may prevent occlusions between the access port and the gastric band. In an embodiment, a valve may be located inside the housing 409 to facilitate operation of the inlets/outlets 440, 442. For example, a three way valve may control the fluid flow between the gastric band, inlet/outlets 440, 442, and an access/injection port.


With reference to FIG. 4A, in one embodiment, a flexible and/or compressible structure 411 may be utilized to give shape to and/or stabilize boundaries of the flexible pouch 410 as it expands and contracts to drain and fill the gastric band. Examples of materials that may be utilized to form the structure 411 are tubes, vertical tubes, synthetic materials, sponge materials, flexible materials, and combinations thereof. The structure 411 may comprise any material that allows fluid to enter and exit the flexible pouch 410 and that does not substantially increase the pressure within the flexible pouch 410.


In various embodiments, the cylinder created by the movable wall 420 has a minimum diameter. For example, at a certain point, the driving mechanism 430 may have exited the housing 409 to the greatest extent possible. Because the minimum diameter may be greater than zero given the structure of the movable wall 420, some space may be left in the flexible pouch 410 when the minimum diameter is achieved. If fluid occupies this space, the reservoir unit 408 may be prone to leakage. However, in an embodiment, an internal structure 413 may be located within the flexible pouch 410 to occupy the space remaining when the minimum diameter is achieved. Thus, less fluid will occupy the remaining space, which reduces the chance of a fluid leak. Furthermore, various gages and other components, such as electronics or pressure sensors, may reside within the internal structure 413 to allow the gastric banding system to be more compact. In some embodiments, the flexible pouch 410 may be donut-shaped and/or crescent shaped to accommodate the internal structure 413.


A pressure sensor may be included in the internal structure 413, such that pressures from the gastric band and/or the flexible pouch 410 may be monitored. The pressure sensor provides a non-invasive method for verifying the functionality of the motor and/or the inflation status of the gastric band. The inclusion of a pressure sensor utilizes additional electronics, such as a driver circuit and two-way communications, with possible modifications to the power electronics of the receiving coil unit and modifications to the external controller for displaying pressure data.


In accordance with further embodiments, the motor 435 may provide different amounts of force as the motor 435 moves the driving mechanism 430 into or out of the housing 409. For example, in an embodiment, the motor 435 may provide less force when moving the driving mechanism 430 into the housing 409 (i.e., increasing the volume in the flexible pouch 410) than when moving the driving mechanism 430 out of the housing 409 (i.e., decreasing the volume in the flexible pouch 410 and moving the fluid to the gastric band). Thus, springs 445, such as coplanar springs, elastic bands, polymer springs, stretchable springs, sheath springs, enclosing springs, or other mechanisms, may be utilized to assist in decreasing the volume within the flexible pouch 410. If springs 445 are utilized, they may assist the motor in compressing the flexible pouch 410 in order to move fluid out of the flexible pouch 410. Further, when expanding the flexible pouch 410, the pressure within the gastric band, together with the power provided by the motor 435, may be sufficient to counteract the compressive force of the springs 445 to allow the flexible pouch 410 to expand.


Although the embodiments illustrated in FIGS. 3A-3B and FIGS. 4A-4D are illustrated as having fluid inlet/outlets 340, 342, 440, 442 that couple an access port to the flexible pouch 310, 410, it should be understood that the access port may also be incorporated into the housing 309, 409 and may be directly coupled to the flexible pouch 310, 410. For example, as illustrated in FIGS. 4E-4G, an access port 414 is incorporated into the housing 409 of the reservoir unit 408 to facilitate filling and draining the reservoir and/or the inflatable portion of the gastric band. With the access port 414 incorporated into the housing 409, a single fluid inlet/outlet 440 may be utilized to fill and drain the gastric band. Although not shown for simplicity in FIGS. 4F-4G, a flexible pouch may be located within the movable wall 420, and fluidic connections may exist between the flexible pouch, the access port 414, and the fluid inlet/outlet 440.


With reference to FIG. 5, in an embodiment, a compression spring 545 may be utilized to help contract the flexible pouch and expel fluid from the flexible pouch. FIG. 5 illustrates a compression wall 520, the driving mechanism 530, and the compression spring 545, but it should be understood that this assembly may be utilized in connection with the other embodiments disclosed herein. For example, the compression wall 520 may facilitate moving a movable wall that wraps around the flexible pouch. As illustrated in FIG. 5, the driving mechanism 530 passes along the inside of the compression wall 520, and the compression spring 545 wraps around the outside of the compression wall 520 to facilitate modifying the position and/or size of the compression wall 520 and moving fluid into or out of the flexible pouch. In other embodiments, the compression spring 545 and the driving mechanism 530 may be located on the same side of the compression wall 520.


In another embodiment, with reference to FIGS. 6A-6D, a sheath 646 may be utilized to assist in expanding or contracting the flexible reservoir in order to fill or drain the inflatable portion of the gastric band. The sheath 646 may comprise an elastic material such as polymers, soft silicone, or springs. The sheath 646 may be used in conjunction with or in place of the movable wall discussed above. The sheath 646 functions to assist the motor 635 as it compresses or squeezes the flexible reservoir. The sheath 646 also resists the motor 635 as it expands and releases pressure on the reservoir, for example, when draining the inflatable portion of the gastric band. In other embodiments, the sheath 635 may resist contraction and assist expansion of the flexible reservoir.


As illustrated in FIG. 6C, the driving mechanism 630 and the motor 635 may be located substantially within the sheath 646. In another embodiment, as illustrated in FIG. 6D, the driving mechanism 630 may be located substantially within a compression sheath 647, and the motor may be located in the motor housing 612. The compression sheath 647 may be utilized in place of a movable wall in order to compress the flexible reservoir. The compression sheath 647 may be made of ePTFE, a foamy material that is rigid in the axis of its cross-section, but compressible and capable of returning to its original length in its longitudinal axis.


The movable wall may comprise different structures and materials according to various embodiments of the present invention. For example, Teflon material may be used for the movable wall, and/or Teflon tape may be utilized to cover the movable wall to reduce friction. In other embodiments, the movable wall may comprise an accordion-type structure. As illustrated in FIG. 6D, the sheath 646 may comprise ePTFE and may be used in place of and/or in addition to the movable wall. Still, in other embodiments, the movable wall may comprise rigid vertical portions circumferentially spaced and connected by thinner flexible portions so that when the movable wall contracts, the flexible portions bend, bringing the vertical portions closer together.


In an embodiment, and with reference to FIG. 7, the reservoir unit 708 and the housing 709 may be configured to house various components of the gastric banding system. For example, the access port 714 may be integrated into the reservoir unit 708, and the housing 709 may have one fluid inlet/outlet 743. The fluid inlet/outlet 743 may be used to fill and drain the inflatable portion of the gastric band using either a subcutaneous injection through a needle-penetrable septum of the access port 714, or by using the internal flexible reservoir. Further, the access port 714 may be utilized to fill or drain the flexible reservoir itself using a subcutaneous injection. The reservoir unit 708 may be sutured to the rectus muscle sheath as discussed above. In an embodiment, a sensing coil (for example, similar to the receiving coil 116 in FIG. 1) for power and communications and the corresponding electronics may also be integrated in the housing 709. Further, in an embodiment, the housing 709 may contain all the wires utilized for the reservoir unit 708 such that the wires do not extend from the reservoir unit 708. Containing the wires in this manner aids in MRI compatibility.


As illustrated in FIG. 7, in an embodiment, the driving mechanism (e.g., a flexible screw) may wrap itself around the periphery of the housing 709 as the motor drives the driving mechanism to expand and contract the movable wall and the reservoir. The lower, larger portion of the housing may be considered the motor housing, with the motor being located in the raised portion that connects the lower, larger portion with the upper, smaller portion. The driving mechanism may be configured to wrap around the periphery of the housing 709 without causing interference with the movement of the movable wall.



FIG. 8 illustrates some of the forces involved in the reservoir unit 808 according to an embodiment of the present invention. One of skill in the art will appreciate that other forces also are involved in the operation of the reservoir unit 808.


“R1” and “R2” in FIG. 8 illustrate two different radii of the cylinder formed by the movable wall 820. The R1 illustrates a radius of the movable wall 820 in an expanded configuration, and the R2 illustrates a smaller radius of the movable wall 820 in a contracted configuration. The driving mechanism 830 wraps around the movable wall 820, and the “L” represents a travel distance of the driving mechanism 830 that results from change in the radius of the movable wall 820 from R1 to R2. The length L is calculated by the formula L=2π(R1−R2). This length, along with knowledge of the pressures P1 and P2, may be used to determine, predict, and/or estimate the forces “F1” and “F2” required by the motor in order to move the movable wall 820 at R1 and R2. Further, the length L may be used to determine, predict, and/or estimate the pressure and/or volume of fluid in the flexible reservoir and/or the inflatable portion of the gastric band.


The pressures “P1” and “P2” represent the pressure exerted by the flexible reservoir against the movable wall 820 when the movable wall 820 is at R1 and R2. As the volume decreases in the flexible reservoir, the surface area of the movable wall 820 against which the pressure is applied decreases (i.e., a decreased diameter of the movable wall 820 leads to a reduced surface area). The resulting force necessary to counteract P1 and P2 and move the driving mechanism 830 is proportional to pressure times the area against which the pressure is applied.


The decrease in area of the movable wall 820 means that less force is utilized to move the driving mechanism 830 at R2 and P2 than at R1 and P1, if the pressure against the movable wall 820 were due solely to fluid in the reservoir. However, because the pressure within the inflatable portion of the gastric band increases with an increased volume, greater force is required to move additional fluid into the gastric band. Thus, the reduced force utilized at R2 and P2 helps to counteract the expected increase in pressure as volume in the gastric band increases. In contrast, where a syringe or plunger-type reservoir is used, the force required to fill the gastric band increases to a greater degree as the gastric band inflates, without any beneficial decrease in the force required to move the constant-area plunger.


Unless otherwise indicated, all numbers expressing quantities of ingredients, volumes of fluids, and so forth used in the specification and claims are to be understood as being modified in all instances by the term “about.” Accordingly, unless indicated to the contrary, the numerical parameters set forth in the specification and attached claims are approximations that may vary depending upon the desired properties sought to be obtained by the present invention. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the invention are approximations, the numerical values set forth in the specific examples are reported as precisely as possible. Any numerical value, however, inherently contains certain errors necessarily resulting from the standard deviation found in their respective testing measurements.


The terms “a,” “an,” “the” and similar referents used in the context of describing the invention (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. Recitation of ranges of values herein is merely intended to serve as a shorthand method of referring individually to each separate value falling within the range. Unless otherwise indicated herein, each individual value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention otherwise claimed. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the invention.


Groupings of alternative elements or embodiments of the invention disclosed herein are not to be construed as limitations. Each group member may be referred to and claimed individually or in any combination with other members of the group or other elements found herein. It is anticipated that one or more members of a group may be included in, or deleted from, a group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is deemed to contain the group as modified thus fulfilling the written description of all Markush groups used in the appended claims.


Certain embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Of course, variations on these described embodiments will become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventor expects skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.


Furthermore, certain references have been made to patents and printed publications throughout this specification. Each of the above-cited references and printed publications are individually incorporated herein by reference in their entirety.


Specific embodiments disclosed herein may be further limited in the claims using consisting of or and consisting essentially of language. When used in the claims, whether as filed or added per amendment, the transition term “consisting of” excludes any element, step, or ingredient not specified in the claims. The transition term “consisting essentially of” limits the scope of a claim to the specified materials or steps and those that do not materially affect the basic and novel characteristic(s). Embodiments of the invention so claimed are inherently or expressly described and enabled herein.


In closing, it is to be understood that the embodiments of the invention disclosed herein are illustrative of the principles of the present invention. Other modifications that may be employed are within the scope of the invention. Thus, by way of example, but not of limitation, alternative configurations of the present invention may be utilized in accordance with the teachings herein. Accordingly, the present invention is not limited to that precisely as shown and described.

Claims
  • 1. An implantable system for use in a gastric band system comprising: a housing having a fluid inlet/outlet;a flexible reservoir positioned within the housing and coupled to an inflatable portion of a gastric band via the fluid inlet/outlet, the flexible reservoir containing a fluid and having an expanded configuration and a contracted configuration;a compression sheath positioned around a circumference of the flexible reservoir forming a cylinder, the compression sheath being movable to change a diameter of the cylinder;a driving mechanism positioned around the compression sheath, the driving mechanism configured to change the diameter of the cylinder to compress the flexible reservoir from the expanded configuration to the contracted configuration, thereby causing a portion of the fluid in the flexible reservoir to move to the inflatable portion of the gastric band; anda motor, coupled to the driving mechanism, the motor capable of actuating the driving mechanism.
  • 2. The implantable system of claim 1 wherein the driving mechanism comprises a flexible screw.
  • 3. The implantable system of claim 2 wherein an end of the flexible screw is attached to the housing.
  • 4. The implantable system of claim 1 wherein the flexible reservoir is formed in a shape selected from a group consisting of a donut, a circle, an ellipse, a rectangle, and combinations thereof.
  • 5. The implantable system of claim 1 further comprising a compressible structure positioned within the flexible reservoir for stabilizing boundaries of the flexible reservoir.
  • 6. The implantable system of claim 1 wherein the motor is coupled to a sensing coil unit that communicates via radio frequency with an external controller for providing power and communications to the motor.
  • 7. The implantable system of claim 1 further comprising a flow control device coupled to the fluid inlet/outlet for controlling movement of the fluid when filling the inflatable portion of the gastric band.
  • 8. The implantable system of claim 7 wherein the flow control device is selected from a group consisting of a valve, a tube, a regulator, and combinations thereof.
  • 9. The implantable system of claim 1 wherein the motor moves the driving mechanism by rotational movement or translational movement.
  • 10. The implantable system of claim 1 further comprising a spring positioned around the compression sheath.
  • 11. The implantable system of claim 10 wherein the spring is selected from a group consisting of an elastic spring, a polymer spring, a stretchable spring, a coplanar spring, a sheath spring, an enclosing spring, and combinations thereof.
  • 12. The implantable system of claim 1 further comprising an access port coupled to the fluid inlet/outlet of the flexible reservoir for filling or draining the flexible reservoir or the inflatable portion of the gastric band.
US Referenced Citations (550)
Number Name Date Kind
1174814 Brennan et al. Mar 1916 A
1830947 Klingel Nov 1931 A
1999683 Borresen Apr 1935 A
2163048 McKee Jun 1939 A
2339138 Black Jan 1944 A
2405667 Ottesen Aug 1946 A
2438231 Schultz et al. Mar 1948 A
2635907 Heimbuch Apr 1953 A
2714469 Carlson Aug 1955 A
2936980 Rapata May 1960 A
3059645 Hasbrouck et al. Oct 1962 A
3189961 Heller Jun 1965 A
3667081 Burger Jun 1972 A
3840018 Heifetz Oct 1974 A
3955834 Ahlrot May 1976 A
4053176 Hilbush Oct 1977 A
4118805 Reimels Oct 1978 A
4133315 Berman et al. Jan 1979 A
4157713 Clarey Jun 1979 A
4176412 Peterson Dec 1979 A
4236521 Lauterjung Dec 1980 A
4271827 Angelchik Jun 1981 A
4299012 Oetiker Nov 1981 A
4340083 Cummins Jul 1982 A
4399809 Baro et al. Aug 1983 A
4406656 Hattler et al. Sep 1983 A
4408597 Tenney, Jr. et al. Oct 1983 A
4417567 Trick Nov 1983 A
4424208 Wallace et al. Jan 1984 A
4442153 Meltsch Apr 1984 A
4450375 Siegal May 1984 A
4485805 Foster, Jr. Dec 1984 A
4492004 Oetiker Jan 1985 A
4551862 Haber Nov 1985 A
4558699 Bashour Dec 1985 A
4559699 Owen et al. Dec 1985 A
4582640 Smestad et al. Apr 1986 A
4582865 Balazs et al. Apr 1986 A
4592339 Kuzmak et al. Jun 1986 A
4592355 Antebi Jun 1986 A
4601713 Fuqua Jul 1986 A
4667672 Romanowski May 1987 A
4671351 Rappe Jun 1987 A
4693695 Cheng Sep 1987 A
4694827 Weiner et al. Sep 1987 A
4696288 Kuzmak et al. Sep 1987 A
4708140 Baron Nov 1987 A
4716154 Malson et al. Dec 1987 A
4753086 Schmidt Jun 1988 A
4760837 Petit Aug 1988 A
4803075 Wallace et al. Feb 1989 A
4881939 Newman Nov 1989 A
4883467 Franetzki et al. Nov 1989 A
4886787 De Belder et al. Dec 1989 A
4896787 Delamour et al. Jan 1990 A
4915690 Cone et al. Apr 1990 A
4925446 Garay et al. May 1990 A
4944487 Holtermann Jul 1990 A
4944659 Labbe et al. Jul 1990 A
4958791 Nakamura Sep 1990 A
4969899 Cox, Jr. Nov 1990 A
4994019 Fernandez et al. Feb 1991 A
5041094 Perego et al. Aug 1991 A
5045060 Melsky et al. Sep 1991 A
5074868 Kuzmak Dec 1991 A
5084061 Gau et al. Jan 1992 A
5089019 Grandjean Feb 1992 A
5091171 Yu et al. Feb 1992 A
5116652 Alzner May 1992 A
5120313 Elftman Jun 1992 A
5143724 Leshchiner et al. Sep 1992 A
5152770 Bengmark et al. Oct 1992 A
5160338 Vincent Nov 1992 A
5188609 Bayless et al. Feb 1993 A
5224494 Enhorning Jul 1993 A
5226429 Kuzmak Jul 1993 A
5246456 Wilkinson Sep 1993 A
5246698 Leshchiner et al. Sep 1993 A
5259399 Brown Nov 1993 A
5326349 Baraff Jul 1994 A
5343894 Frisch et al. Sep 1994 A
5356883 Kuo et al. Oct 1994 A
5360445 Goldowsky Nov 1994 A
5391156 Hildwein et al. Feb 1995 A
5399351 Leshchiner et al. Mar 1995 A
5449363 Brust et al. Sep 1995 A
5449368 Kuzmak Sep 1995 A
5458568 Racchini et al. Oct 1995 A
5496312 Klicek Mar 1996 A
5509888 Miller Apr 1996 A
5531716 Luzio et al. Jul 1996 A
5535752 Halperin et al. Jul 1996 A
5554113 Novak et al. Sep 1996 A
5562714 Grevious Oct 1996 A
5601604 Vincent Feb 1997 A
5607418 Arzbaecher Mar 1997 A
5633001 Agerup May 1997 A
5653718 Yoon Aug 1997 A
5658298 Vincent et al. Aug 1997 A
5676162 Larson, Jr. et al. Oct 1997 A
5695504 Gifford, III et al. Dec 1997 A
5704893 Timm Jan 1998 A
5713911 Racenet et al. Feb 1998 A
5733257 Sternby Mar 1998 A
5748200 Funahashi May 1998 A
5759015 Van Lintel et al. Jun 1998 A
5766232 Grevious et al. Jun 1998 A
5769877 Barreras, Sr. Jun 1998 A
5785295 Tsai Jul 1998 A
5807311 Palestrant Sep 1998 A
5817113 Gifford, III et al. Oct 1998 A
5827529 Ono et al. Oct 1998 A
5833698 Hinchliffe et al. Nov 1998 A
5861014 Familoni Jan 1999 A
RE36176 Kuzmak Mar 1999 E
5886042 Yu et al. Mar 1999 A
5904697 Gifford, III et al. May 1999 A
5910149 Kuzmak Jun 1999 A
5928195 Malamud et al. Jul 1999 A
5938669 Klaiber et al. Aug 1999 A
5944696 Bayless et al. Aug 1999 A
5944751 Laub Aug 1999 A
5993473 Chan et al. Nov 1999 A
6013679 Kuo et al. Jan 2000 A
6024340 Lazarus et al. Feb 2000 A
6024704 Meador et al. Feb 2000 A
6042345 Bishop et al. Mar 2000 A
6048309 Flom et al. Apr 2000 A
6067991 Forsell May 2000 A
6074341 Anderson et al. Jun 2000 A
6074378 Mouri et al. Jun 2000 A
6083249 Familoni Jul 2000 A
6090131 Daley Jul 2000 A
6102922 Jakobsson et al. Aug 2000 A
6164933 Tani et al. Dec 2000 A
6171321 Gifford, III et al. Jan 2001 B1
6193734 Bolduc et al. Feb 2001 B1
6203523 Haller et al. Mar 2001 B1
6210345 Van Brunt Apr 2001 B1
6210347 Forsell Apr 2001 B1
6221024 Miesel Apr 2001 B1
6224857 Romeo et al. May 2001 B1
6306088 Krausman et al. Oct 2001 B1
6327503 Familoni Dec 2001 B1
6371965 Gifford, III et al. Apr 2002 B2
6372494 Naughton et al. Apr 2002 B1
6383218 Sourdile et al. May 2002 B1
6383219 Telandro et al. May 2002 B1
6387105 Gifford, III et al. May 2002 B1
6417750 Sohn Jul 2002 B1
6418934 Chin Jul 2002 B1
6419696 Ortiz et al. Jul 2002 B1
6432040 Meah Aug 2002 B1
6439539 Powell Aug 2002 B1
6443957 Addis Sep 2002 B1
6443965 Gifford, III et al. Sep 2002 B1
6450173 Forsell Sep 2002 B1
6450946 Forsell Sep 2002 B1
6450987 Kramer Sep 2002 B1
6451034 Gifford, III et al. Sep 2002 B1
6453907 Forsell Sep 2002 B1
6454699 Forsell Sep 2002 B1
6454700 Forsell Sep 2002 B1
6454701 Forsell Sep 2002 B1
6454785 De Hoyos Garza Sep 2002 B2
6457801 Fish et al. Oct 2002 B1
6460543 Forsell Oct 2002 B1
6461293 Forsell Oct 2002 B1
6463935 Forsell Oct 2002 B1
6464628 Forsell Oct 2002 B1
6470892 Forsell Oct 2002 B1
6474584 Ekich Nov 2002 B2
6475136 Forsell Nov 2002 B1
6485496 Suyker et al. Nov 2002 B1
6491704 Gifford, III et al. Dec 2002 B2
6491705 Gifford, III et al. Dec 2002 B2
6511490 Robert Jan 2003 B2
6517556 Monassevitch Feb 2003 B1
6527701 Sayet et al. Mar 2003 B1
6547801 Dargent et al. Apr 2003 B1
6565582 Gifford, III et al. May 2003 B2
6579301 Bales et al. Jun 2003 B1
6601604 Cooper Aug 2003 B1
6615084 Cigaina Sep 2003 B1
6627620 Nielsen Sep 2003 B1
6630486 Royer Oct 2003 B1
6632239 Snyder et al. Oct 2003 B2
6646628 Shirochi et al. Nov 2003 B2
6676674 Dudai Jan 2004 B1
6681135 Davis et al. Jan 2004 B1
6685668 Cho et al. Feb 2004 B1
6685963 Taupin et al. Feb 2004 B1
6691047 Fredericks Feb 2004 B1
6715731 Post et al. Apr 2004 B1
6729600 Mattes et al. May 2004 B2
6754527 Stroebel et al. Jun 2004 B2
6767924 Yu et al. Jul 2004 B2
6811136 Eberhardt et al. Nov 2004 B2
6820651 Seuret et al. Nov 2004 B2
6834201 Gillies et al. Dec 2004 B2
6871090 He et al. Mar 2005 B1
6889086 Mass et al. May 2005 B2
6916326 Benchetrit Jul 2005 B2
6921819 Piron et al. Jul 2005 B2
6924273 Pierce Aug 2005 B2
6940467 Fischer et al. Sep 2005 B2
6966875 Longobardi Nov 2005 B1
7017583 Forsell Mar 2006 B2
7017883 Bayer et al. Mar 2006 B2
7021147 Subramanian et al. Apr 2006 B1
7037344 Kagan et al. May 2006 B2
7040349 Moler et al. May 2006 B2
7048519 Fong et al. May 2006 B2
7054690 Imran May 2006 B2
7058434 Wang et al. Jun 2006 B2
7060080 Bachmann Jun 2006 B2
7066486 Lee Jun 2006 B2
7118526 Egle Oct 2006 B2
7119062 Alvis et al. Oct 2006 B1
7128750 Stergiopulos Oct 2006 B1
7144400 Byrum et al. Dec 2006 B2
7172607 Hofle et al. Feb 2007 B2
7177693 Starkebsum Feb 2007 B2
7191007 Desai et al. Mar 2007 B2
7198250 East Apr 2007 B2
7204821 Clare et al. Apr 2007 B1
7206637 Salo Apr 2007 B2
7223239 Schulze et al. May 2007 B2
7238191 Bachmann Jul 2007 B2
7240607 Fish Jul 2007 B2
7255675 Gertner et al. Aug 2007 B2
7263405 Boveja et al. Aug 2007 B2
7282023 Frering Oct 2007 B2
7284966 Xu et al. Oct 2007 B2
7288064 Boustani et al. Oct 2007 B2
7297103 Jarsaillon et al. Nov 2007 B2
7299082 Feldman et al. Nov 2007 B2
7310557 Maschino et al. Dec 2007 B2
7311503 Van Lintel et al. Dec 2007 B2
7311716 Byrum Dec 2007 B2
7311717 Egle Dec 2007 B2
7314443 Jordan et al. Jan 2008 B2
7314636 Caseres et al. Jan 2008 B2
7338433 Coe Mar 2008 B2
7340306 Barrett et al. Mar 2008 B2
7351198 Byrum et al. Apr 2008 B2
7351240 Hassler, Jr. et al. Apr 2008 B2
7353747 Swayze et al. Apr 2008 B2
7364542 Jambor et al. Apr 2008 B2
7366571 Armstrong Apr 2008 B2
7367340 Nelson et al. May 2008 B2
7367937 Jambor et al. May 2008 B2
7374565 Hassler, Jr. et al. May 2008 B2
7390294 Hassler Jun 2008 B2
7396353 Lorenzen et al. Jul 2008 B2
7416528 Crawford et al. Aug 2008 B2
7457668 Cancel et al. Nov 2008 B2
7481763 Hassler et al. Jan 2009 B2
7500944 Byrum et al. Mar 2009 B2
7502649 Ben-Haim et al. Mar 2009 B2
7530943 Lechner May 2009 B2
7594885 Byrum Sep 2009 B2
7599743 Hassler, Jr. et al. Oct 2009 B2
7599744 Giordano et al. Oct 2009 B2
7601162 Hassler, Jr. et al. Oct 2009 B2
7615001 Jambor et al. Nov 2009 B2
7618365 Jambor et al. Nov 2009 B2
7658196 Ferreri et al. Feb 2010 B2
7670279 Gertner Mar 2010 B2
7699770 Hassler, Jr. et al. Apr 2010 B2
7712470 Gertner May 2010 B2
7727141 Hassler, Jr. et al. Jun 2010 B2
7741476 Lebreton Jun 2010 B2
7758493 Gingras Jul 2010 B2
7763039 Ortiz et al. Jul 2010 B2
7766815 Ortiz Aug 2010 B2
7771439 Griffiths Aug 2010 B2
7775215 Hassler, Jr. et al. Aug 2010 B2
7775966 Dlugos et al. Aug 2010 B2
7775967 Gertner Aug 2010 B2
7794386 Brooks Sep 2010 B2
7811298 Birk Oct 2010 B2
7824422 Benchetrit Nov 2010 B2
7828813 Mouton Nov 2010 B2
7832407 Gertner Nov 2010 B2
7841978 Gertner Nov 2010 B2
7844342 Dlugos et al. Nov 2010 B2
7862502 Pool et al. Jan 2011 B2
7879068 Dlugos et al. Feb 2011 B2
7951067 Byrum et al. May 2011 B2
20010011543 Forsell Aug 2001 A1
20020072780 Foley Jun 2002 A1
20020091395 Gabbay Jul 2002 A1
20020095181 Beyar Jul 2002 A1
20020098097 Singh Jul 2002 A1
20020139208 Yatskov Oct 2002 A1
20020183765 Adams Dec 2002 A1
20020193679 Malave et al. Dec 2002 A1
20020198548 Robert Dec 2002 A1
20030014003 Gertner Jan 2003 A1
20030019498 Forsell Jan 2003 A1
20030045775 Forsell Mar 2003 A1
20030045902 Weadock Mar 2003 A1
20030055311 Neukermans et al. Mar 2003 A1
20030060873 Gertner et al. Mar 2003 A1
20030066536 Forsell Apr 2003 A1
20030073880 Polsky et al. Apr 2003 A1
20030093157 Caseres et al. May 2003 A1
20030100910 Gifford, III et al. May 2003 A1
20030120288 Benchetrit Jun 2003 A1
20030148995 Piron et al. Aug 2003 A1
20030158564 Benchetrit Aug 2003 A1
20030158569 Wazne Aug 2003 A1
20030181890 Schulze et al. Sep 2003 A1
20030181917 Gertner Sep 2003 A1
20030191433 Prentiss Oct 2003 A1
20030208212 Cigaina Nov 2003 A1
20040000843 East Jan 2004 A1
20040044332 Stergiopulos Mar 2004 A1
20040049209 Benchetrit Mar 2004 A1
20040059393 Policker et al. Mar 2004 A1
20040068847 Belisle et al. Apr 2004 A1
20040106899 McMichael et al. Jun 2004 A1
20040133219 Forsell Jul 2004 A1
20040147816 Policker et al. Jul 2004 A1
20040148034 Kagan et al. Jul 2004 A1
20040153106 Dudai Aug 2004 A1
20040162595 Foley Aug 2004 A1
20040215159 Forsell Oct 2004 A1
20040230137 Mouton Nov 2004 A1
20040254536 Conlon et al. Dec 2004 A1
20040254537 Conlon et al. Dec 2004 A1
20040260319 Egle Dec 2004 A1
20040267288 Byrum et al. Dec 2004 A1
20040267291 Byrum et al. Dec 2004 A1
20040267292 Byrum et al. Dec 2004 A1
20040267293 Byrum et al. Dec 2004 A1
20040267377 Egle Dec 2004 A1
20050002984 Byrum et al. Jan 2005 A1
20050038484 Knudson et al. Feb 2005 A1
20050038498 Dubrow et al. Feb 2005 A1
20050055039 Burnett et al. Mar 2005 A1
20050070934 Tanaka et al. Mar 2005 A1
20050070937 Jambor et al. Mar 2005 A1
20050100779 Gertner May 2005 A1
20050104457 Jordan et al. May 2005 A1
20050119672 Benchetrit Jun 2005 A1
20050119674 Gingras Jun 2005 A1
20050131383 Chen et al. Jun 2005 A1
20050131485 Knudson et al. Jun 2005 A1
20050136122 Sadozai et al. Jun 2005 A1
20050142152 Leshchiner et al. Jun 2005 A1
20050143765 Bachmann et al. Jun 2005 A1
20050143766 Bachmann et al. Jun 2005 A1
20050154274 Jarsaillon et al. Jul 2005 A1
20050171568 Duffy Aug 2005 A1
20050183730 Byrum Aug 2005 A1
20050192531 Birk Sep 2005 A1
20050192601 Demarais Sep 2005 A1
20050192614 Binmoeller Sep 2005 A1
20050192629 Saadat et al. Sep 2005 A1
20050216042 Gertner Sep 2005 A1
20050226936 Agerup Oct 2005 A1
20050228415 Gertner Oct 2005 A1
20050228504 Demarais Oct 2005 A1
20050240155 Conlon Oct 2005 A1
20050240156 Conlon Oct 2005 A1
20050240279 Kagan et al. Oct 2005 A1
20050244288 O'Neill Nov 2005 A1
20050250979 Coe Nov 2005 A1
20050251181 Bachmann Nov 2005 A1
20050251182 Bachmann Nov 2005 A1
20050267406 Hassler, Jr. Dec 2005 A1
20050267500 Hassler, Jr. et al. Dec 2005 A1
20050267533 Gertner Dec 2005 A1
20050271729 Wang Dec 2005 A1
20050277899 Conlon et al. Dec 2005 A1
20050283041 Egle Dec 2005 A1
20050288739 Hassler Dec 2005 A1
20050288740 Hassler, Jr. et al. Dec 2005 A1
20060015138 Gertner Jan 2006 A1
20060020298 Camilleri et al. Jan 2006 A1
20060041183 Massen et al. Feb 2006 A1
20060074439 Garner et al. Apr 2006 A1
20060074473 Gertner Apr 2006 A1
20060089571 Gertner Apr 2006 A1
20060122147 Wohlrab Jun 2006 A1
20060142700 Sobelman et al. Jun 2006 A1
20060142790 Gertner Jun 2006 A1
20060161139 Levine et al. Jul 2006 A1
20060161186 Hassler et al. Jul 2006 A1
20060167531 Gertner et al. Jul 2006 A1
20060173238 Starkebaum Aug 2006 A1
20060173424 Conlon Aug 2006 A1
20060178555 Bortolotti Aug 2006 A1
20060183967 Lechner Aug 2006 A1
20060189887 Hassler, Jr. et al. Aug 2006 A1
20060189888 Hassler, Jr. et al. Aug 2006 A1
20060189889 Gertner Aug 2006 A1
20060194758 Lebreton Aug 2006 A1
20060195139 Gertner Aug 2006 A1
20060197412 Rasmussen Sep 2006 A1
20060199997 Hassler, Jr. et al. Sep 2006 A1
20060211912 Dlugos et al. Sep 2006 A1
20060211913 Dlugos et al. Sep 2006 A1
20060211914 Hassler, Jr. et al. Sep 2006 A1
20060212051 Snyder et al. Sep 2006 A1
20060212053 Gertner Sep 2006 A1
20060235448 Roslin et al. Oct 2006 A1
20060246137 Hermitte et al. Nov 2006 A1
20060247721 Maschino et al. Nov 2006 A1
20060247722 Maschino et al. Nov 2006 A1
20060247724 Gerber et al. Nov 2006 A1
20060252982 Hassler, Jr. et al. Nov 2006 A1
20060252983 Lembo et al. Nov 2006 A1
20060257488 Hubbard Nov 2006 A1
20060264699 Gertner Nov 2006 A1
20060276812 Hill et al. Dec 2006 A1
20060293627 Byrum et al. Dec 2006 A1
20070015954 Dlugos Jan 2007 A1
20070015955 Tsonton Jan 2007 A1
20070015956 Crawford et al. Jan 2007 A1
20070016231 Jambor et al. Jan 2007 A1
20070016262 Gross et al. Jan 2007 A1
20070027356 Ortiz Feb 2007 A1
20070027358 Gertner et al. Feb 2007 A1
20070044655 Fish Mar 2007 A1
20070077292 Pinsky Apr 2007 A1
20070078476 Hull, Sr. et al. Apr 2007 A1
20070125826 Shelton Jun 2007 A1
20070156013 Birk Jul 2007 A1
20070167672 Dlugos et al. Jul 2007 A1
20070167982 Gertner et al. Jul 2007 A1
20070173685 Jambor et al. Jul 2007 A1
20070173888 Gertner et al. Jul 2007 A1
20070179335 Gertner et al. Aug 2007 A1
20070185373 Tsonton Aug 2007 A1
20070185462 Byrum Aug 2007 A1
20070213836 Paganon Sep 2007 A1
20070218083 Brooks Sep 2007 A1
20070232848 Forsell Oct 2007 A1
20070232849 Gertner Oct 2007 A1
20070233170 Gertner Oct 2007 A1
20070235083 Dlugos Oct 2007 A1
20070243227 Gertner Oct 2007 A1
20070250085 Bachmann et al. Oct 2007 A1
20070250086 Wiley et al. Oct 2007 A1
20070255335 Herbert et al. Nov 2007 A1
20070255336 Herbert et al. Nov 2007 A1
20070265598 Karasik Nov 2007 A1
20070265645 Birk et al. Nov 2007 A1
20070265646 McCoy et al. Nov 2007 A1
20070293716 Baker et al. Dec 2007 A1
20070298005 Thibault Dec 2007 A1
20080009680 Hassler, Jr. Jan 2008 A1
20080015406 Dlugos et al. Jan 2008 A1
20080015501 Gertner Jan 2008 A1
20080027269 Gertner Jan 2008 A1
20080027469 Bachmann Jan 2008 A1
20080071306 Gertner Mar 2008 A1
20080097496 Chang et al. Apr 2008 A1
20080108862 Jordan et al. May 2008 A1
20080147002 Gertner Jun 2008 A1
20080161717 Gertner Jul 2008 A1
20080161875 Stone Jul 2008 A1
20080166028 Turek et al. Jul 2008 A1
20080167647 Gertner Jul 2008 A1
20080167648 Gertner Jul 2008 A1
20080172072 Pool et al. Jul 2008 A1
20080188766 Gertner Aug 2008 A1
20080195092 Kim et al. Aug 2008 A1
20080208240 Paz Aug 2008 A1
20080221598 Dlugos et al. Sep 2008 A1
20080243071 Quijano et al. Oct 2008 A1
20080249806 Dlugos Oct 2008 A1
20080250340 Dlugos et al. Oct 2008 A1
20080250341 Dlugos et al. Oct 2008 A1
20080255403 Voegele et al. Oct 2008 A1
20080255414 Voegele et al. Oct 2008 A1
20080255425 Voegele et al. Oct 2008 A1
20080255459 Voegele et al. Oct 2008 A1
20080255537 Voegele et al. Oct 2008 A1
20080275294 Gertner Nov 2008 A1
20080275295 Gertner Nov 2008 A1
20080275484 Gertner Nov 2008 A1
20080281347 Gertner Nov 2008 A1
20080287969 Tsonton et al. Nov 2008 A1
20080287974 Widenhouse et al. Nov 2008 A1
20080287976 Weaner et al. Nov 2008 A1
20080300618 Gertner Dec 2008 A1
20080319435 Rioux et al. Dec 2008 A1
20090054914 Lechner Feb 2009 A1
20090062825 Pool et al. Mar 2009 A1
20090062826 Steffen Mar 2009 A1
20090082793 Birk Mar 2009 A1
20090118572 Lechner May 2009 A1
20090149874 Ortiz et al. Jun 2009 A1
20090157106 Marcotte et al. Jun 2009 A1
20090157107 Kierath et al. Jun 2009 A1
20090157113 Marcotte et al. Jun 2009 A1
20090171375 Coe et al. Jul 2009 A1
20090171378 Coe et al. Jul 2009 A1
20090171379 Coe et al. Jul 2009 A1
20090187202 Ortiz et al. Jul 2009 A1
20090192404 Ortiz et al. Jul 2009 A1
20090192415 Ortiz et al. Jul 2009 A1
20090192533 Dlugos, Jr. et al. Jul 2009 A1
20090192534 Ortiz et al. Jul 2009 A1
20090192541 Ortiz et al. Jul 2009 A1
20090198261 Schweikert Aug 2009 A1
20090202387 Dlugos, Jr. et al. Aug 2009 A1
20090204131 Ortiz et al. Aug 2009 A1
20090204132 Ortiz et al. Aug 2009 A1
20090204141 Dlugos, Jr. et al. Aug 2009 A1
20090204179 Dlugos, Jr. et al. Aug 2009 A1
20090209995 Byrum et al. Aug 2009 A1
20090216255 Coe et al. Aug 2009 A1
20090220176 Fusco Sep 2009 A1
20090222031 Axelsson Sep 2009 A1
20090222065 Dlugos, Jr. et al. Sep 2009 A1
20090228063 Dlugos, Jr. et al. Sep 2009 A1
20090228072 Coe et al. Sep 2009 A1
20090270904 Birk et al. Oct 2009 A1
20090306462 Lechner Dec 2009 A1
20090312785 Stone et al. Dec 2009 A1
20100010291 Birk et al. Jan 2010 A1
20100049224 Vargas Feb 2010 A1
20100087843 Bertolote et al. Apr 2010 A1
20100099945 Birk et al. Apr 2010 A1
20100100079 Berkcan Apr 2010 A1
20100145378 Gertner Jun 2010 A1
20100152532 Marcotte Jun 2010 A1
20100168508 Gertner Jul 2010 A1
20100185049 Birk et al. Jul 2010 A1
20100191265 Lau et al. Jul 2010 A1
20100191271 Lau et al. Jul 2010 A1
20100204647 Gertner Aug 2010 A1
20100204723 Gertner Aug 2010 A1
20100217071 Ricol Aug 2010 A1
20100226988 Lebreton Sep 2010 A1
20100228080 Tavori et al. Sep 2010 A1
20100234682 Gertner Sep 2010 A1
20100249803 Griffiths Sep 2010 A1
20100280310 Raven Nov 2010 A1
20100305397 Birk et al. Dec 2010 A1
20100312046 Lau et al. Dec 2010 A1
20100312147 Gertner Dec 2010 A1
20100324358 Birk et al. Dec 2010 A1
20100324359 Birk Dec 2010 A1
20110201874 Birk et al. Aug 2011 A1
Foreign Referenced Citations (130)
Number Date Country
949965 Jun 1974 CA
1250382 Apr 2000 CN
1367670 Sep 2002 CN
4225524 Feb 1994 DE
10020688 Dec 2000 DE
0119596 Sep 1984 EP
0230747 Aug 1987 EP
0416250 Mar 1991 EP
0611561 Aug 1994 EP
0695558 Feb 1996 EP
0876808 Nov 1998 EP
1036545 Sep 2000 EP
1072282 Jan 2001 EP
1105073 Jun 2001 EP
1396242 Mar 2004 EP
1396243 Mar 2004 EP
1491167 Dec 2004 EP
1491168 Dec 2004 EP
1529502 May 2005 EP
1547549 Jun 2005 EP
1574189 Sep 2005 EP
1600183 Nov 2005 EP
1602346 Dec 2005 EP
1704833 Sep 2006 EP
1719480 Nov 2006 EP
1754890 Nov 2006 EP
1736123 Dec 2006 EP
1736195 Dec 2006 EP
1736202 Dec 2006 EP
1743605 Jan 2007 EP
1829504 Sep 2007 EP
1829505 Sep 2007 EP
1829506 Sep 2007 EP
1967168 Sep 2008 EP
1992315 Nov 2008 EP
2074970 Jul 2009 EP
2074971 Jul 2009 EP
2074972 Jul 2009 EP
2087862 Aug 2009 EP
2095796 Sep 2009 EP
2095798 Sep 2009 EP
2191796 Jun 2010 EP
1566202 May 1969 FR
2688693 Sep 1993 FR
2769491 Apr 1999 FR
2783153 Mar 2000 FR
2797181 Feb 2001 FR
2799118 Apr 2001 FR
2823663 Oct 2002 FR
2855744 Dec 2004 FR
2921822 Apr 2009 FR
1174814 Dec 1969 GB
2090747 Jul 1982 GB
57-171676 Oct 1982 JP
1-67309 Apr 1989 JP
2-019147 Jan 1990 JP
2-132104 Nov 1990 JP
3-105702 Nov 1991 JP
11-244395 Sep 1999 JP
2003-526410 Sep 2003 JP
2005-131380 May 2005 JP
2005-334658 Dec 2005 JP
8503144 Dec 1986 SE
WO 8600079 Jan 1986 WO
WO 8600912 Feb 1986 WO
WO 8911701 Nov 1989 WO
WO 9000369 Jan 1990 WO
WO 9220349 Nov 1992 WO
WO 9402517 Feb 1994 WO
WO 9633751 Jan 1996 WO
WO 9835639 Aug 1998 WO
WO 9835640 Aug 1998 WO
WO 0000108 Jan 2000 WO
WO 0001428 Jan 2000 WO
WO 0009047 Feb 2000 WO
WO 0009048 Feb 2000 WO
WO 0009049 Feb 2000 WO
WO 0015158 Mar 2000 WO
WO 0066196 Nov 2000 WO
WO 0110359 Feb 2001 WO
WO 0112078 Feb 2001 WO
WO 0141671 Jun 2001 WO
WO 0147435 Jul 2001 WO
WO 0147575 Jul 2001 WO
WO 0149245 Jul 2001 WO
WO 0152777 Jul 2001 WO
WO 0168007 Sep 2001 WO
WO 0170131 Sep 2001 WO
WO 0185071 Nov 2001 WO
WO 0205753 Jan 2002 WO
WO 0209792 Feb 2002 WO
WO 0219953 Mar 2002 WO
WO 0226317 Apr 2002 WO
WO 02053093 Jul 2002 WO
WO 02065948 Aug 2002 WO
WO 02096326 Dec 2002 WO
WO 03007782 Jan 2003 WO
WO 03055420 Jul 2003 WO
WO 03057092 Jul 2003 WO
WO 03059215 Jul 2003 WO
WO 03077191 Sep 2003 WO
WO 03101352 Dec 2003 WO
WO 03105732 Dec 2003 WO
WO 2004014245 Feb 2004 WO
WO 2004019671 Mar 2004 WO
WO 2004108025 Dec 2004 WO
WO 2004112563 Dec 2004 WO
WO 2005007232 Jan 2005 WO
WO 2005009305 Feb 2005 WO
WO 2005067994 May 2005 WO
WO 2005072195 Aug 2005 WO
WO 2005087147 Sep 2005 WO
WO 2005094447 Oct 2005 WO
WO 2005112888 Dec 2005 WO
WO 2006040647 Apr 2006 WO
WO 2006049725 May 2006 WO
WO 2006083885 Aug 2006 WO
WO 2006108203 Oct 2006 WO
WO 2007067206 Jun 2007 WO
WO 2007081304 Jul 2007 WO
WO 2007106727 Sep 2007 WO
WO 2007114905 Oct 2007 WO
WO 2007145638 Dec 2007 WO
WO 2008063673 May 2008 WO
WO 2008109300 Sep 2008 WO
WO 2008134755 Nov 2008 WO
WO 2009050709 Apr 2009 WO
WO 2009132127 Oct 2009 WO
WO 2009136126 Nov 2009 WO
WO 2010042493 Apr 2010 WO
Non-Patent Literature Citations (88)
Entry
Acuna-Goycolea et al.; “Mechanism of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Inhibition of Identified Green Fluorescent Protein-Expressing GABA Neurons in the Hypothalamic Neuroendocrine Acruate Nucleus”; The Journal of Neuroscience; V. 25(32); pp. 7406-7419; Aug. 10, 2005.
Adrian et al.; “Mechanism of Pancreatic Polypeptide Release in Man.” The Lancet; pp. 161-163; Jan. 22, 1977.
Anson; “Shape Memory Alloys—Medical Applications,” Source: Materials World, vol. 7, No. 12, pp. 745-747, Dec. 1999.
Asakawa et al; “Antagonism of Ghrelin Receptor Reduces Food Intake and Body Weight Gain in Mice”; Gut.; V.52; pp. 947-952; 2003.
Baggio et al. “Biology of Incretins: GLP-1 and GIP”; Gastroenrology; V. 132; pp. 2131-2157; 2007.
Ballantyne; “Peptide YY(1-36) and Peptide YY(3-36): Part I. Distribution, Release, and Actions”; Obesity Surgery; V.16; pp. 651-658; 2006.
Ballantyne; “Peptide YY(1-36) and Peptide YY(3-36): Part II. Changes after Gastrointestinal Surgery and Bariatric Surgery”; Obesity Surgery; V.16; pp. 795-803; 2006.
Berne et al; “Physiology”; V. 5; pp. 55-57, 210, 428, 540, 554, 579, 584, 591; 2004.
BioEnterics Lap-Band Adjustable Gastric Banding System, Inamed Health, pub., pp. 1-115; Aug. 28, 2003.
Boulant et al.; “Cholecystokinin in Transient Lower Oesophageal Sphincter Relaxation Due to Gastric Distension in Humans”; Gut.; V. 40; pp. 575-581; 1997.
Bradjewin et al.; “Dose Ranging Study of the Effects of Cholecystokinin in Healthy Volunteers”; J. Psychiatr. Neurosci.; V. 16 (2); pp. 91-95; 1991.
Burdyga et al.; “Cholecystokinin Regulates Expression of Y2 Receptors in Vagal Afferent Neurons Serving the Stomach”; The Journal of Neuroscience; V. 28; No. 45; pp. 11583-11592; Nov. 5, 2008.
Chaptini et al.; “Neuroendocrine Regulation of Food Intake”; Current Opinion in Gastroenterology; V. 24; pp. 223-229; 2008.
Chaudhri; “Can Gut Hormones Control Appetite and Prevent Obesity?” Diabetes Care; V. 31; Supp 2; pp. S284-S289; Feb. 2008.
Cohen et al.; “Oxyntomodulin Suppresses Appetite and Reduces Food Intake in Humans”; J. Clin. Endocrinol. Metab.; V. 88; No. 10; pp. 4696-4701; 2003.
Corno et al.; “A new implantable device for telemetric control of pulmonary blood flow”; New ideas; received Apr. 24, 2004; received in revised form Jul. 12, 2002; 10 pages.
Corno et al.; “FlowWatchTM in clipped and in clipped position”; Interact Cardio Vase Thorac Surg 2002; 1:46-49; Copyright @ 2002 The European Association for Cardio-thoracic Surgery; 1 page.
Cummings et al.; “Plasma Ghrelin Levels After Diet-Induced Weight Loss or Gastric Bypass Surgery”; N. Engl J. Med; V. 346, No. 21; pp. 1623-1630; May 23, 2002.
Cummings; “Gastrointestinal Regulation of Foot Intake”; The Food Journal of Clinical Investigation; V. 117, N. 1; pp. 13-23; Jan. 2007.
Dakin et al.; “Oxyntomodulin Inhibits Food Intake in the Rat”; Endocrinology; V. 142; No. 10; pp. 4244-4250; 2001.
Dakin et al.; “Peripheral Oxyntomodulin Reduces Food Intake and Body Weight gain in Rats”; Endocrinology; V. 145; No. 6; pp. 2687-2695; Jun. 2004.
Davison; “Activation of Vagal-Gastric Mechanoreceptors by Cholecystokinin”; Proc. West. Pharmocol. Soc.; V. 29; pp. 363-366; 1986.
De Waele et al.; “Endoscopic Volume Adjustment of Intragastric Balloons for Intolerance”; Obesity Surgery; V. 11; pp. 223-224;2001.
De Waele et al.; “Intragastric Balloons for Preoperative Weight Reduction”; Obesity Surgery; V. 58; pp. 58-60; 2001.
Desai et al.; “Molecular Weight of Heparin Using 13C Nuclear Magnetic Resonance Spectroscopy” Journal of Pharmaceutical Science, V. 84, I 2; 1995, Abstract only.
Doldi et al.; “Intragastric Balloon: Another Option for Treatment of Obesity and Morbid Obesity”; Hepato-Gastroenterology; V. 51, N. 55; pp. 294-307; Jan.-Feb. 2004.
Doldi et al.; “Treatment of Morbid Obesity with Intragastric Balloon in Association with Diet”; Obesity Surgery; V. 10, pp. 583-587; 2000.
Doldi et al; “Intragastric Balloon in Obese Patients”; Obesity Surgery; V. 10, 578-581; 2000.
Ekblad et al.; “Distribution of Pancreatic Peptide and Peptide-YY”; Peptides; V. 23; pp. 251-261; 2002.
El Khoury et al.; “Variation in Postprandial Ghrelin Status Following Ingestion of High-Carbohydrate, High Fat, and High Protein Meals in Males”; Ann Nutr Metab; V. 50; pp. 260-269; 2006.
Galloro et al; “Preliminary Endoscopic Technical Report of an New Silicone Intragastric Balloon in the Treatment of Morbid Obesity”; Obesity Surgery; V. 9, pp. 68-71; 1999.
GinShiCel MH Hydroxy Propyl Methyl Cellulose, Web Page http://www.ginshicel.cn/MHPC.html, Nov. 12, 2008.
Girard; “The incretins: From the concept to their use in the treatment of type 2 diabetes. Part A: Incretins: Concept and physiological functions”; Diabetes and Metabolism; V. 34; pp. 550-559; 2008.
Greenough et al.; “Untangling the Effects of Hunger, Anxiety, and Nausea on Energy Intake During Intravenous Cholecystokinin Octapeptide (CCK-8) Infusion”; Physiology & Behavior; V. 65, No. 2; pp. 303-310; 1998.
Grise et al.; “Peptide YY Inhibits Growth of Human Breast Cancer in Vitro and in Vivo”; Journal of Surgical Research; V. 82; pp. 151-155; 1999.
Grundy; “Signaling the State of the Digestive Tract”; Autonomic Neuroscience: Basic and Clinical; V. 125; pp. 76-80; 2006.
Grundy; “Vagal Control of Gastrointestinal Function”; Bailliere's Clinical Gastroenterology; V. 2; No. 1; pp. 23-43; 1988.
Hallden et al. “Evidence for a Role of the Gut Hormone PYY in the Regulation of Intestinal Fatty Acid Binding Protein Transcripts in Differentiated Subpopulations of Intestinal Epithelial Cell Hybrids”; Journal of Biological Chemistry; V. 272 (19); pp. 125916-126000; 1997.
Hameed et al.; “Gut hormones and appetite control.” Oral Diseases; V. 15; pp. 18-26; 2009.
Hassan et al.; “Effects of Adjuvants to Local Anesthetics on Their Duration III Experimental Studies of Hyaluronic Acid” Abstract Pub Med [Acta Anesthesiol Scand.; 29 (4): 384-8], 1 page; May 1985.
Hodson et al.; “Management of Obesity with the New Intragastric Balloon”; Obesity Surgery;.V. 11, pp. 327-329, 2001.
Holzer; “Gastrointestinal Afferents as Targets of Novel Drugs for the Treatment of Functional Bowel Disorders and Visceral Pain”; European Journal of Pharmacology; V. 429; pp. 177-193; 2001.
Houpt; “Gastrointestinal Factors in Hunger and Satiety.” Neuroscience and Behavioral Reviews; V. 6; pp. 145-164; 1982.
Iverson et al.; “Recent Advances in Microscale Pumping Technologies: A Review and Evaluation”; Microfluid Nanofluid; vol. 5; pp. 145-174; Feb. 19, 2008.
Jones; “Molecular, pharmacological, and clinical aspects of liraglutide, a oncedaily human GLP-1 analogue”; Molecular and Cellular Endocrinology; V. 297; pp. 137-140; 2009.
Kerem et al.; “Exogenous Ghrelin Enhances Endocrine and Exocrine Regeneration in Pancreatectomized Rats”; J Gastrointest Surg.; V.13; pp. 775-783, 2009.
Kesty et al.; “Hormone-based therapies in the regulation of fuel metabolism and body weight”; Expert Opin. Biol. Ther.; V. 8; No. 11; pp. 1733-1747; 2008.
Kissileff et al.; “Peptides that Regulate Food Intake: Cholecystokinin and Stomach Distension Combine to Reduce Food Intake in Humans”; Am. J. Physiol. Regul. Integr. Comp. Physiol; V. 285; pp. 992-998; 2003.
Kojima et al.; “A role for pancreatic polypeptide in feeding and body weight regulation.” Peptides; V. 28; pp. 459-463; 2007.
Kulicke et al. “Visco-Elastic Propeerties of Sodium Hyaluronate Solutions,” American Institute of Physics; pp. 585-587; 2008.
Lap-Band AP System Adjustable Gastric Banding System With OmniformTM Design: Directions for Use (DFU); Allergan, 16 pages; 2009.
Le Roux et al.; “Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters”; Ann. Surg; V. 243; No. 1; pp. 108-114; Jan. 2006.
Liu et al.; “Adjuvant Hormonal Treatment With Peptide YY or Its Analog Decreases Human Pancreatic Carcinoma Growth”; The American Journal of Surgery; V. 171; pp. 192-196; Jan. 1996.
Mathus-Vliegen et al. “Intragastric Balloons for Morbid Obesity: Results, Patient Tolerance and Balloon Life Span”; Br. J. Surg.; V. 77, No. 7, pp. 76-79; Jan. 1990.
Mathus-Vliegen et al. “Treating Morbid and Supermorbid Obesity” International Journal of Gastroenterology; V. 5, No. 1, pp. 9-12; 2000.
Medeiros et al.; “Processing and metabolism of Peptide-YY: Pivotal roles of Dipeptidase-IV, Aminopeptidase-P, and Endopeptidase-24.11”; Endocrinology; V. 134, No. 5; pp. 2088-2094; 1994.
Naslund et al. “Pranidal subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects”; British Journal of Nutrition; V. 91; pp. 439-446; 2004.
Potier et al.; “Protein, amino acids, and the control of food intake”; Current Opinion in Clinical Nutrition and Metabolic Care; V. 12; pp. 54-58; 2009.
Qian et al.; “Pulmonary delivery of a GLP-1 receptor agonist, BMS-686117”; International Journal of Pharmaceutics; V. 366; pp. 218-220; 2008.
Rang et al.; “Pharmacology”; V. 5; pp. 203, 397, 402, 524; 2004.
Raybould et al.; “Integration of Postprandial Gastrointestinal Tract: Role of CCK and Sensory Pathways”; Annals of New York Academy of Science; pp. 143-156; 1994.
Renshaw et al. “Peptide YY: A Potential Therapy for Obesity”; Current Drug Targets; V. 6; pp. 171-179; 2005.
Sannino et al.; “Crosslinking of Cellulose Derivatives and Hyaluronic Acid with Water-Soluble Carbodiimide” Polymer 46; pp. 11206-11212; 2005.
Shechter et al.; “Reversible PEGylation of peptide YY3-36 prolongs its inhibition of food intake in mice”; FEBS Letters; V. 579; pp. 2439-2444; 2005.
Silver et al.; “Physical Properties of Hyaluronic Acid and Hydroxypropylmethylcellulose in Solution: Evaluation of Coating Abillity” Journal of Applied Biomaterials, V. 5; pp. 89-98, 1994.
Small et al.; “Gut hormones and the control of appetite”; Trends in Endocrinology and Metabolism; V. 15. No. 6; pp. 259-263; Aug. 2004.
Stanley et al.; “Gastrointestinal Satiety Signals III. Glucagon-like Peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide”; Am. J. Physiol Gastrointest Liver Physiol; V. 286; pp. 693-697; 2004.
Tezel; “The Science of Hyaluronic Acid Dermal Fillers,” Journal of Cosmetic and Laser Therapy (2008) 10: pp. 35-42.
Tolhurst et al.; “Nutritional regulation of glucagon-like peptide1 secretion”; J. Physiol.; V. 587, No. 1; pp. 27-32; 2009.
Totte et al.; “Weight Reduction by Means of Intragastric Device: Experience with the Bioenterics Intragastric Balloon”; Obesity Surgery; V. 11, pp. 519-523; 2001.
Tough et al.; “Y4 Receptors Mediate the Inhibitory Responses of Pancreatic Polypeptide in Human and Mouse Colon Mucosa”; The Journal of Pharmacology and Experimental Therapeutics; V. 319, No. 1; pp. 20-30; 2006.
Tseng et al; “Peptide YY and cancer: Current findings and potential clinical applications”; Peptides; V. 23; pp. 389-395; 2002.
Valassi et al.; “Neuroendocrine control of food intake”; Nut. Metab. & Cariovasc. Disease; V. 18; pp. 158-168; 2008.
Van Der Lely et al.; “Biological, Physiological, Pathophysiological Aspects of Ghrelin”; Endocrine Reviews; V. 25, No. 3; pp. 426-457; 2004.
Verdich et al. “A Meta-Analysis of the Effect of Glucagon-Like-Peptide-1 (7-36) Amide on ad Libitum Energy Intake in Humans”; J. Clin. Endocrinal. Metab. V. 86; pp. 4382-4389; Sep. 2001.
Wahlen et al.; “The BioEnterics Intragastric Balloon (BIB): How to Use It”; Obesity Surgery; V. 11; pp. 524-527; 2001.
Wang et al.; “Plasma Ghrelin Modulation in Gastric Band Operation and Sleeve Gastrectomy”; Obes. Surg.; pp. 357-362; 2008.
Weiner et al.; “Preparation of Extremely Obese Patients for Laparoscopic Gastric Banding by Gastric Balloon Therapy”; Obesity Surgery; V. 9, pp. 261-264, 1999.
Wynne et al.; “Subcutaneous Oxyntomodulin Reduces Body Weight in Overweight and Obese Subjects: A Double-Blind Randomized, Controlled Trial”; Diabetes; V. 54; pp. 2390-2395; 2005.
Yuzuriha et al.; “Gastrointestinal Hormones (anorexigenic peptide YY and orexigenic ghrelin) influence neural tube development”; FASEB J.; V. 21; pp. 2108-2112; 2007.
Brown et al; “Symmetrical Pouch Dilation After Laparoscopic Adjustable Gastric Banding: Incidence and Management”; Obesity Surgery; V. 18, pp. 1104-1108; 2008.
Ceelen et al.; “Surgical Treatment of Severe Obesity With a Low-Pressure Adjustable Gastric Band: Experimental Data and Clinical Results in 625 Patients”; Annals of Surgery; V. 237, No. 1; pp. 10-16; 2003.
Dixon et al.; “Pregnancy After Lap-Band Surgery: Management of the Band to Achieve Healthy Weight Outcomes”; Obesity Surgery; V. 11, pp. 59-65; 2001.
Neary et al.; “Peptide YY(3-36) and Glucagon-Like Peptide-1(7-36) Inhibit Food Intake Additively”; Endocrinology; V.146; pp. 5120-5127; 2005.
Padidela et al.; “Elevated basal and post-feed glucagon-like petide 1 (GLP-1) concentrations in the neonatel period”; European Journal of Endocrinology; v. 160; pp. 53-58; 2009.
Shi et al.; “Sexually Dimorphic Responses to Fat Loss After Caloric Restriction or Surgical Lipectomy”; Am. J. Physiol. Endocrinol. Metab.; V. 293; E316-E326; 2007.
Xanthakos et al.; “Bariatric Surgery for Extreme Adolescent Obesity: Indications, Outcomes, and Physiologic Effects on the Gut-Brain Axis”; Pathophysiology; V. 15; pp. 135-146; 2008.
U.S. Appl. No. 12/705,245, filed Feb. 12, 2010, Birk, et al.
Related Publications (1)
Number Date Country
20110306824 A1 Dec 2011 US